A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jun Zhang, Master
Xiamen University
Study Chair - Long Sui, Ph.D.
Obstetrics & Gynecology Hospital of Fudan University
Principal Investigator - Xiaoqiang Liu, Ph.D.
Yunnan Provincial Center for Disease Control and Prevention
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fujian Provincial Center for Disease Control and Prevention
Fuzhou, Fujian, China
- Sichuan Provincial Center for Disease Control and Prevention
Chengdu, Sichuan, China
- Yunnan Provincial Center for Disease Control and Prevention
Kunming, Yunnan, China
- Zhejiang Provincial Center for Disease Control and Prevention
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Apr 2025
- Primary completion
- 30 Sept 2031
- Completion
- 30 Sept 2031
- Last update posted
- 31 Jul 2025
- Registered enrollment
- 9,300
- Registry id
- NCT06866574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.